Will the "best" news be saved for Monday afternoon when the stock market is closed? We'll see, but for now enjoy a recap of the biotech news dump from Friday evening 6/30. Part 2 will follow if warranted!
$CYCC increases proposed offering to $26.7m from $15m through Ladenburg, tons of warrants coming on this one.
— Shane Blackmon (@shaneblackmon) June 30, 2017
$FLXN $300m shelf offering filed
— Shane Blackmon (@shaneblackmon) June 30, 2017
Isoray $ISR executive raises.
Alder Biopharma $ALDR details on clinical trial results.
VTV Therapeutics $VTVT NASDAQ delisting notice.
Sunesis Pharma $SNSS restructures debt, contingent on raising cash 2h17.
Orexigen Therapeutics $OREX NASDAQ delisting notice.
Fortress Biotech $FBIO CFO resigns.
Therapix Biosciences $TRPX - two directors resign.
Alder Biopharma $ALDR details on clinical trial results.
VTV Therapeutics $VTVT NASDAQ delisting notice.
Sunesis Pharma $SNSS restructures debt, contingent on raising cash 2h17.
Orexigen Therapeutics $OREX NASDAQ delisting notice.
Fortress Biotech $FBIO CFO resigns.
Therapix Biosciences $TRPX - two directors resign.
RSS Feed
